The reasons why the whole industry is repurposing drugs

Finding new therapeutic uses for old drugs is a growing trend in the industry. as pharma struggles to discover new blockbuster drugs and see in the practice a way to rebuild their pipelines. Although drug repositioning may sound a strategy only applicable for big pharmaceutical, but small spin-out biotechs are taking advantage of the declining cost of screening of small …

Evaluating the Discovering New Therapeutic Uses for Existing Molecules program

In putting the agenda and speakers together for the World Drug Repositioning Congress USA, I came up with a lot of opposing views on the NIH's pilot program on the subject. Of course that for a pilot program, there are no expectations that the project will be flawless, in the meantime it should be targeted to really encourage and set …

“Crowd sourcing drug development”. Can it really lead to drug repositioning?

After the NCATS pilot program ‘Discovering New Therapeutic Uses for Existing Molecules' was launched in May, a lot has been discussed about its potential and the actual feasibility to reposition one or some of the 58 compounds contributed by the eight big pharma joining the project. Experts in the field of drug repurposing say that there's very little opportunity for …